Prague Med. Rep. 2021, 122, 80-95
https://doi.org/10.14712/23362936.2021.9
Comparison of the Chemiluminescence Immunoassay LIAISON® with the Radioimmunoassay for Aldosterone and Renin Measurement
References
1. , M., Kang, F. A., Orloff, E., Amar, J., Chamontin, B., Bouchanick, B. (2015) Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension. Ann. Cardiol. Angeiol. (Paris) 64, 169–174.
<https://doi.org/10.1016/j.ancard.2015.04.017>
2. , N., Georges, A., Brosaaud, J., Corcuff, J. B. (2015) Aldosterone determination: Comparison of a RIA assay and CLIA assay. Clin. Biochem. 48, 89–92.
<https://doi.org/10.1016/j.clinbiochem.2014.10.008>
3. , J., Buffolo, F., Monticone, S., Viola, A., Falcetta, A., Lucchiari, M., Mengozzi, G., Rabbia, F., Veglio, F., Mulatero, P. (2015) Comparison between aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay for the diagnosis of primary aldosteronism. J. Hypertens. 33, e121.
<https://doi.org/10.1097/01.hjh.0000467678.01436.87>
4. , C. A., Toole, B. J., Alvarez-Madrazo, S., Kelly, A., Connell, J. M., Wallace, A. M. (2010) A screening procedure for primary aldosteronism based on the Diasorin LIAISON® automated chemiluminescent immunoassay for direct renin. Ann. Clin. Biochem. 47, 195–199.
<https://doi.org/10.1258/acb.2010.009230>
5. , C., Houillier, P., Nussberger, J., Girerd, X. (2016) SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps. Ann. Endocrinol. (Paris) 77, 192–201.
<https://doi.org/10.1016/j.ando.2016.02.003>
6. , P., Jeske, W., Bednarek-Papierska, L., Kruszynska, A., Gietka-Czernel, M., Roslonowska, E., Slowinska-Srzednicka, J., Kasperlik-Zaluska, A., Zglyzinski, W. (2015) The ratios of aldosterone/plasma renin activity (ARR) versus aldosterone/direct renin concentration (ADRR). J. Renin Angiotensin Aldosterone Syst. 16, 1298–1305.
<https://doi.org/10.1177/1470320313519487>
7. , P., Shaw, S. G., Nicod, J., Saner, E., Nussberger, J. (2004) Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. J. Hypertens. 22, 377–381.
<https://doi.org/10.1097/00004872-200402000-00023>
8. , D., Lőcsei, Z., Csizmadia, Z., Toldy, E., Szabolcs, I., Rácz, K. (2012) Clinical evaluation of the renin-aldosterone system: Comparison of two methods in different clinical conditions. Orv. Hetil. 153, 1701–1710. (in Hungarian)
<https://doi.org/10.1556/OH.2012.29476>
9. , P. M., van den Born, B. J., Frenkel, W. J., de Brujine, E. L., Deinum, J., Kerstens, M. N., Smulders, Y. M., Woittiez, A. J., Wijbenga, J. A., Zietse, R., Danser, A. H., van den Meiracker, A. H. (2014) Test characteristics of the aldosterone-to renin ratio as a screening test for primary aldosteronism. J. Hypertens. 32, 115–126.
<https://doi.org/10.1097/HJH.0b013e3283656b54>
10. , C., Bassani, N., Gritti, A., Biganzoli, E., Morganti, A. (2014) Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension. J. Hypertens. 32, 627–634.
<https://doi.org/10.1097/HJH.0000000000000076>
11. , L., Song, Y., Mei, M., He, W., Hu, J., Cheng, Q., Tang, Z., Luo, T., Wang, Y., Zhen, Q., Wang, Z., Qing, H., He, Y., Li, Q., Yang, S.; the Chongqing Primary Aldosteronism Study (CONPASS) Group (2018) Age-related cutoffs of plasma aldosterone/renin concentration for primary aldosteronism screening. Int. J. Endocrinol. 2018, 8647026.
12. , J. E., Diamandis, E. P., Holmes, D., Stowasser, M., Auchus, R., Cavalier, E. (2015) A renin-ssance in primary aldosteronism testing: Obstacles and opportunities for screening, diagnosis, and management. Clin. Chem. 61, 1022–1027.
<https://doi.org/10.1373/clinchem.2015.242990>
13. , M., Seiler, L., Rump, L. C. (2003) Normokaliämisher primärer hyperaldosteronismus. Dtsch. Arztebl. 100, 184–190.
14. , E. M. L., Delfino, L., Fierro, F., Santoro, S., Peréz, M., Caruso, G., Glikman, P., Gauna, S., Lupi, S. (2019) Primary aldosteronism: Aldosterone/renin ratio cut-off points. Endocrinol. Diabetes Nutr. 66, 361–367.
<https://doi.org/10.1016/j.endinu.2018.11.008>
15. , S., Seifarth, C., Schobel, H., Hahn, E. G., Hensen, J. (2002) Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. Exp. Clin. Endocrinol. Diabetes 110, 80–85.
<https://doi.org/10.1055/s-2002-23491>
16. , A., Fuentes, C. A., Barros, E. R., Martínez-Aguayo, A., García, H., Allende, F., Solari, S., Olmos, R., Carvajal, C., Topia-Castillo, A., Campino, C., Kalergis, A. M., Baundrand, R., Fardella, C. E. (2019) The aldosterone/renin ratio predicts cardiometabolic disorders in subjects without classic primary aldosteronism. Am. J. Hypertens. 32, 468–475.
<https://doi.org/10.1093/ajh/hpz023>
17. , Y. N., Scanlon, M. J., Barnes, S. C. (2011) The clinical utility of two renin mass methods to detect primary hyperaldosteronism compared with renin activity. Ann. Clin. Biochem. 48, 256–262.
<https://doi.org/10.1258/acb.2010.010171>
